Table 2.
Statistically significant deletions identified in elevated stearic acid mutant lines by Comparative Genome Hybridization technique
| CGH comparison | Fold ratio (neg = deletion) | CHR | ~ deletion start | ~ deletion end | Deletion size (bps) | % CHR affected | SACPD-C | Glyma1 gene models affected |
|---|---|---|---|---|---|---|---|---|
| FN8/W82 |
−1.08 |
Gm14 |
34,116,388 |
34,523,951 |
407,563 |
0.82% |
ΔSACPD-C |
12 |
| MM106/Bay |
−0.83 |
Gm11 |
10,333,512 |
10,335,676 |
2,164 |
0.01% |
|
1 (partial) |
| −1.71 |
Gm14 |
32,288,267 |
34,779,838 |
2,491,571 |
5.01% |
ΔSACPD-C |
80 (2 partial) |
|
| −1.84 |
Gm18 |
4,557,847 |
4,560,113 |
2,266 |
0.00% |
|
None |
|
| −1.13 |
Gm18 |
4,582,012 |
4,584,221 |
2,209 |
0.00% |
|
1 (partial, low confidence) |
|
| KK24or M25/Bay |
−2.48 |
Gm11 |
4,376,963 |
4,559,394 |
182,431 |
0.47% |
|
26 |
| −0.65 |
Gm11 |
10,329,096 |
10,359,964 |
30,868 |
0.08% |
|
3 + 2 (partial) |
|
| |
N/A |
Gm14 |
34324782 |
34324782 |
1 |
<.0001% |
C298Δ |
Glyma14g27990 |
| A6/FA8077 | −1.43 |
Gm02 |
4,858,850 |
4,863,246 |
4,396 |
0.01% |
|
|
| −2.32 |
Gm02 |
40,861,581 |
41,125,894 |
264,313 |
0.51% |
|
|
|
| −0.75 |
Gm09 |
8,937,856 |
8,940,059 |
2,203 |
0.00% |
|
None |
|
| −0.49 |
Gm10 |
6,316,784 |
6,325,045 |
8,261 |
0.02% |
|
1 (partial) |
|
| −0.77 |
Gm10 |
39,664,757 |
39,689,162 |
24,405 |
0.05% |
|
4 |
|
| −0.96 |
Gm10 |
40,573,756 |
40,575,906 |
2,150 |
0.00% |
|
None |
|
| −0.67 |
Gm10 |
40,672,171 |
40,679,285 |
7,114 |
0.01% |
|
None |
|
| −1.74 |
Gm10 |
41,199,204 |
41,201,464 |
2,260 |
0.00% |
|
1 (partial) |
|
| −1.29 |
Gm11 |
37,009,044 |
37,029,501 |
20,457 |
0.05% |
|
4 |
|
| −1.39 |
Gm14 |
33,716,793 |
39,937,769 |
6,220,976 |
12.51% |
ΔSACPD-C |
143 |
|
| −0.59 | Gm15 | 19,611,579 | 19,640,675 | 29,096 | 0.06% | 1 + 1 (partial) |